Focal Area of Research in Oncology (FARO) is a leading research network based in the Basel region, dedicated to advancing the field of cancer biology. With a focus on both solid and hematological malignancies, FARO fosters interdisciplinary collaboration and accelerates the translation of basic research into clinical applications, aiming to benefit cancer patients through cutting-edge innovations. FARO supports research on critical aspects of cancer biology, including ex vivo and in vivo models for studying mechanisms of tumor growth, drug resistance, metastasis, and personalized cancer therapies. By integrating expertise across disciplines, the network enhances collaboration between academia, clinical settings, and the pharmaceutical industry in Basel. FARO also promotes international exchange among oncologists to keep the research community at the forefront of global advancements. To strengthen knowledge sharing, FARO organizes a range of activities, including the annual Oncoday Symposium in Basel, scientific retreats, lecture series, and guest lectures, providing a platform for discussing the latest oncological research and innovations. 

The network brings together approximately 200 researchers from 20 research groups, spanning the Faculty of Medicine and Faculty of Science at the University of Basel, University Hospital Basel, and the Department of Biosystems Science and Engineering at ETH Zurich in Basel.